Harcourt Terrace Nursing And Rehabilitation | |
8181 Harcourt Rd, Indianapolis, Indiana 46260 | |
(317) 872-7261 | |
Name | Harcourt Terrace Nursing And Rehabilitation |
---|---|
Location | 8181 Harcourt Rd, Indianapolis, Indiana |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 110 |
Occupancy Rate | 65.55% |
Medicare ID (CCN) | 155149 |
Legal Business Name | The Health And Hospital Corporation Of Marion County |
Ownership Type | Government - County |
NPI Number | 1114085677 |
Organization Name | THE HEALTH AND HOSPITAL CORPORATION OF MARION COUNTY |
Doing Business As | HARCOURT TERRACE NURSING AND REHABILITATION |
Address | 8181 Harcourt Rd, Indianapolis, IN 46260 |
Phone Number | 317-872-7261 |
News Archive
Providing patients with direct access to their imaging test results could improve patient satisfaction and clinical outcomes. However, physicians are concerned that it could lead to increased patient anxiety and unrealistic demands on physician time, according to a study in the April issue of the Journal of the American College of Radiology (www.jacr.org).
Now, Regeneron Pharmaceuticals says its COVID-19 antibody-drug cocktail under development prevented and treated the disease in monkeys and hamsters, showing promise that it may work in humans.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome.
Low-carbohydrate, high-protein diets—like the Atkins diet—have been popular among dieters for years. For just as long, experts have worried that such diets might be harmful to the kidneys. A study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN) looks into these safety concerns.
There have been numerous studies on the safety and efficacy of using vitamin E to treat nondiabetic patients with nonalcoholic steatohepatitis (NASH), but researchers at the annual meeting of the American Association for the Study of Liver Diseases presented results of vitamin E in diabetic and nondiabetic patients.
› Verified 5 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Providing patients with direct access to their imaging test results could improve patient satisfaction and clinical outcomes. However, physicians are concerned that it could lead to increased patient anxiety and unrealistic demands on physician time, according to a study in the April issue of the Journal of the American College of Radiology (www.jacr.org).
Now, Regeneron Pharmaceuticals says its COVID-19 antibody-drug cocktail under development prevented and treated the disease in monkeys and hamsters, showing promise that it may work in humans.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome.
Low-carbohydrate, high-protein diets—like the Atkins diet—have been popular among dieters for years. For just as long, experts have worried that such diets might be harmful to the kidneys. A study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN) looks into these safety concerns.
There have been numerous studies on the safety and efficacy of using vitamin E to treat nondiabetic patients with nonalcoholic steatohepatitis (NASH), but researchers at the annual meeting of the American Association for the Study of Liver Diseases presented results of vitamin E in diabetic and nondiabetic patients.
› Verified 5 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $73782 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 15.64 | 14.46 |
Percentage of long-stay residents who lose too much weight | 15.77 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 79.78 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.73 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 3.13 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0.72 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.64 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 24.68 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 73.5 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 7.14 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 22.47 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 10.32 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.64 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 75.24 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 84.68 | 82.93 |
News Archive
Providing patients with direct access to their imaging test results could improve patient satisfaction and clinical outcomes. However, physicians are concerned that it could lead to increased patient anxiety and unrealistic demands on physician time, according to a study in the April issue of the Journal of the American College of Radiology (www.jacr.org).
Now, Regeneron Pharmaceuticals says its COVID-19 antibody-drug cocktail under development prevented and treated the disease in monkeys and hamsters, showing promise that it may work in humans.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome.
Low-carbohydrate, high-protein diets—like the Atkins diet—have been popular among dieters for years. For just as long, experts have worried that such diets might be harmful to the kidneys. A study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN) looks into these safety concerns.
There have been numerous studies on the safety and efficacy of using vitamin E to treat nondiabetic patients with nonalcoholic steatohepatitis (NASH), but researchers at the annual meeting of the American Association for the Study of Liver Diseases presented results of vitamin E in diabetic and nondiabetic patients.
› Verified 5 days ago
Community Nursing And Rehabilitation Center Location: 5600 E 16th St, Indianapolis, Indiana 46218 Phone: (317) 356-0911 | |
Northwest Manor Health Care Center Location: 6440 W 34th St, Indianapolis, Indiana 46224 Phone: (317) 293-4930 | |
Golden Living Center-brookview Location: 7145 E 21st Street, Indianapolis, Indiana 46219 Phone: (317) 356-0977 | |
Golden Living Center-indianapolis Location: 2860 Churchman Ave, Indianapolis, Indiana 46203 Phone: (317) 787-3451 |